Lea Ziporen

1.5k total citations
26 papers, 1.1k citations indexed

About

Lea Ziporen is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, Lea Ziporen has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Rheumatology, 11 papers in Hematology and 6 papers in Immunology. Recurrent topics in Lea Ziporen's work include Systemic Lupus Erythematosus Research (15 papers), Platelet Disorders and Treatments (10 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (4 papers). Lea Ziporen is often cited by papers focused on Systemic Lupus Erythematosus Research (15 papers), Platelet Disorders and Treatments (10 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (4 papers). Lea Ziporen collaborates with scholars based in Israel, France and United States. Lea Ziporen's co-authors include Yehuda Shoenfeld, Maja Hojnik, Jacob George, Zvi Fishelson, Yair Levy, Natalie Donin, Amos D. Korczyn, Michael Kirschfink, K. Jurianz and Miri Blank and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Blood.

In The Last Decade

Lea Ziporen

26 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lea Ziporen Israel 15 637 358 277 220 162 26 1.1k
Maria Tiziana Bertero Italy 17 560 0.9× 401 1.1× 199 0.7× 276 1.3× 99 0.6× 43 1.3k
H. Englert Australia 20 631 1.0× 238 0.7× 260 0.9× 231 1.1× 79 0.5× 41 1.3k
Mary‐Carmen Amigo Mexico 23 1.3k 2.1× 605 1.7× 308 1.1× 204 0.9× 141 0.9× 50 1.6k
José Ordi-Ros Spain 11 987 1.5× 468 1.3× 146 0.5× 175 0.8× 96 0.6× 18 1.2k
R A Asherson United Kingdom 17 1.1k 1.7× 448 1.3× 305 1.1× 116 0.5× 93 0.6× 27 1.4k
Cinzia Testoni Italy 16 973 1.5× 373 1.0× 507 1.8× 129 0.6× 48 0.3× 18 1.3k
Yehuda Shoenfeld Israel 17 949 1.5× 280 0.8× 612 2.2× 71 0.3× 90 0.6× 32 1.3k
Francesca Bellisai Italy 21 611 1.0× 171 0.5× 313 1.1× 70 0.3× 109 0.7× 62 1.1k
Toshiyuki Aramaki Japan 21 734 1.2× 170 0.5× 329 1.2× 139 0.6× 61 0.4× 76 1.2k
Rohan Willis United States 19 1.1k 1.7× 589 1.6× 317 1.1× 178 0.8× 58 0.4× 51 1.3k

Countries citing papers authored by Lea Ziporen

Since Specialization
Citations

This map shows the geographic impact of Lea Ziporen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lea Ziporen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lea Ziporen more than expected).

Fields of papers citing papers by Lea Ziporen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lea Ziporen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lea Ziporen. The network helps show where Lea Ziporen may publish in the future.

Co-authorship network of co-authors of Lea Ziporen

This figure shows the co-authorship network connecting the top 25 collaborators of Lea Ziporen. A scholar is included among the top collaborators of Lea Ziporen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lea Ziporen. Lea Ziporen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mardamshina, Mariya, Metsada Pasmanik‐Chor, Lea Ziporen, et al.. (2019). MicroRNAs Affect Complement Regulator Expression and Mitochondrial Activity to Modulate Cell Resistance to Complement-Dependent Cytotoxicity. Cancer Immunology Research. 7(12). 1970–1983. 7 indexed citations
2.
Rozenberg, Perri, et al.. (2018). Cooperation between Hsp90 and mortalin/GRP75 in resistance to cell death induced by complement C5b-9. Cell Death and Disease. 9(2). 150–150. 22 indexed citations
3.
Ziporen, Lea, et al.. (2009). Programmed Necrotic Cell Death Induced by Complement Involves a Bid-Dependent Pathway. The Journal of Immunology. 182(1). 515–521. 30 indexed citations
4.
Ziporen, Lea, Amos D. Korczyn, Iris Goldberg, et al.. (2004). Neurological Dysfunction Associated with Antiphospholipid Syndrome: Histopathological Brain Findings of Thrombotic Changes in a Mouse Model. Journal of Immunology Research. 11(1). 67–75. 28 indexed citations
5.
Donin, Natalie, et al.. (2003). Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid. Clinical & Experimental Immunology. 131(2). 254–263. 120 indexed citations
6.
Mader, Reuven, Lea Ziporen, Lily Neumann, & Dan Buskila. (2002). Antiphospholipid Antibodies in a Heterogeneous Group of Patients: Experience from a Central Laboratory. Clinical Rheumatology. 21(5). 386–390. 3 indexed citations
7.
Afek, Arnon, Y Shoenfeld, Riri S. Manor, et al.. (1999). Increased endothelial cell expression of a3β1 integrin in cardiac valvulopathy in the primary (Hughes) and secondary antiphospholipid syndrome. Lupus. 8(7). 502–507. 37 indexed citations
8.
Levy, Yair, Lea Ziporen, J Clèdes, et al.. (1998). Massive Proteinuria as a Main Manifestation of Primary Antiphospholipid Syndrome. Pathobiology. 66(1). 49–52. 21 indexed citations
9.
Shoenfeld, Yehuda & Lea Ziporen. (1998). Lessons from experimental APS models. Lupus. 7(2_suppl). 158–161. 22 indexed citations
10.
Bordron, Anne, Maryvonne Dueymes, Yair Levy, et al.. (1998). Anti-endothelial cell antibody binding makes negatively charged phospholipids accessible to antiphospholipid antibodies. Arthritis & Rheumatism. 41(10). 1738–1747. 39 indexed citations
11.
Ziporen, Lea, Gowthami M. Arepally, Yehuda Shoenfeld, et al.. (1998). Defining an Antigenic Epitope on Platelet Factor 4 Associated With Heparin-Induced Thrombocytopenia. Blood. 92(9). 3250–3259. 106 indexed citations
12.
Bordron, Anne, Maryvonne Dueymes, Yair Levy, et al.. (1998). Anti‐endothelial cell antibody binding makes negatively charged phospholipids accessible to antiphospholipid antibodies. Arthritis & Rheumatism. 41(10). 1738–1747. 3 indexed citations
13.
Ziporen, Lea, Yehuda Shoenfeld, Yair Levy, & Amos D. Korczyn. (1997). Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model.. Journal of Clinical Investigation. 100(3). 613–619. 88 indexed citations
14.
Ziporen, Lea, et al.. (1997). ANIMAL MODELS FOR ANTIPHOSPHOLIPID SYNDROME IN PREGNANCY. Rheumatic Disease Clinics of North America. 23(1). 99–117. 12 indexed citations
15.
Baharav, Ehud, H Gur, Pnina Fishman, et al.. (1997). Superantigens and experimental SLE induced by idiotypic dysregulation.. PubMed. 14(4). 359–66. 1 indexed citations
16.
Hojnik, Maja, Jacob George, Lea Ziporen, & Yehuda Shoenfeld. (1996). Heart Valve Involvement (Libman-Sacks Endocarditis) in the Antiphospholipid Syndrome. Circulation. 93(8). 1579–1587. 298 indexed citations
17.
Dueymes, Maryvonne, Yair Levy, Lea Ziporen, et al.. (1996). Do some antiphospholipid antibodies target endothelial cells?. PubMed. 147 Suppl 1. 22–3. 13 indexed citations
18.
Ziporen, Lea, Iris Goldberg, Michael Arad, et al.. (1996). Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves. Lupus. 5(3). 196–205. 119 indexed citations
19.
Gilburd, Boris, Lea Ziporen, Dorit Zharhary, et al.. (1994). Antimitochondrial (pyruvate dehydrogenase) antibodies in leprosy. Journal of Clinical Immunology. 14(1). 14–19. 23 indexed citations
20.
Hojnik, Maja, Boris Gilburd, Lea Ziporen, et al.. (1994). Anticardiolipin Antibodies in Infections are Heterogenous in Their Dependency on β 2-Glycoprotein I: Analysis of Anticardiolipin Antibodies in Leprosy. Lupus. 3(6). 515–521. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Tiziana Bertero Breakdown of academic impact, for papers by H. Englert Breakdown of academic impact, for papers by Mary‐Carmen Amigo Breakdown of academic impact, for papers by José Ordi-Ros Breakdown of academic impact, for papers by R A Asherson Breakdown of academic impact, for papers by Cinzia Testoni Breakdown of academic impact, for papers by Yehuda Shoenfeld Breakdown of academic impact, for papers by Francesca Bellisai Breakdown of academic impact, for papers by Toshiyuki Aramaki Breakdown of academic impact, for papers by Rohan Willis
Rankless by CCL
2026